StockWatch
·

BAJAJ FINSERV LTD. Q1 FY27 Results

BAJAJFINSVQ1 FY27 Results
Filing
Result:Steady· Market: SurgedOne-off gain

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue42.0K Cr9.2%18.6%
Total Income42.0K Cr9.2%18.6%
Expenditure33.1K Cr4.8%17.2%
PBT8.9K Cr29.1%23.9%
Net Profit6.3K Cr20.5%18.1%
OPM40.78%3.08pp0.39pp
NPM14.98%1.41pp0.05pp
EPS19.6023.3%12.0%
View full financials

Adjusted owners' PAT grew just ~12% YoY (and only ~5% excluding FVTPL mark-to-market gains) as strong 28% PAT growth at Bajaj Finance was largely offset by a weaker general/life insurance segment and diluted by minority interest, making this an in-line rather than standout quarter.

BAJAJ FINSERV · Q1 FY-2027 · THE VERDICT

Operations Strong, Capital Gains Fade Dims the Profit Picture

Consolidated revenue grew 18.6%, but profit growth lagged at 18.2% as insurance subsidiaries faced capital gains collapse and underwriting stress. The operational story—Life VNB +87%, Finance AUM +24%—is solid; the reported number is muddied by soft equity markets and a soft insurance pricing environment.

05 Aug 2026 · 6 min read
Consolidated Revenue

₹42,037 Cr

+18.6% YoY

Consolidated PAT

₹6,297 Cr

+18.2% YoY

Bajaj Life VNB

₹271 Cr

+87% YoY; NBM +480 bps

Bajaj General Profit

₹478 Cr

−27% YoY; COR 103.9%

Bajaj Finance PAT

₹6,081 Cr

+27.6% YoY; AUM +24%

The headline is tidy—revenue +18.6%, PAT +18.2%—but hiding underneath is a tale of operational strength smothered by non-recurring headwinds. Bajaj Finance and Housing are firing (AUM +24% respectively; Finance PAT +27.6%). Bajaj Life's operational metrics are exceptional (VNB +87%, new business margin expanded 480 bps to 15.9%), proving the turnaround strategy is working. Yet consolidated PAT growth trails revenue growth, and two of the four operating subsidiaries—General Insurance and Life Insurance—reported profit declines of 27% and 70% respectively, despite strong underwriting and volume growth. The reason: a capital gains drought in soft equity markets and underwriting stress in General Insurance.

Where the profit compression came from

Bajaj General Insurance profit fell 27% to ₹478 Cr despite holding the best-in-industry combined ratio of 103.9% (vs. ~120% industry average). The culprit: no equity capital gains in Q1 due to subdued market conditions, combined with elevated underwriting losses (₹130 Cr vs ₹116 Cr prior year) from a soft pricing cycle across all segments. Bajaj Life faced an even starker fall—PAT down 70% to ₹51 Cr—despite VNB surging 87% to ₹271 Cr. Management attributed this to capital gains absence and a 290 basis-point GST headwind, offset only partially by cost discipline (Bajaj Life 2.0). The implication is clear: reported earnings are hostage to the equity market cycle and insurance pricing conditions, while the operational franchises are executing well.

Because the equity markets were subdued, so we didn't really have any equity gains that were realized and recorded in the P&L during this quarter.

Claims vs. what holds up

Management's key assertions
  • Bajaj Life VNB +87% YoY to ₹271 Cr; turnaround executing

  • Bajaj General COR 103.9% best-in-industry despite soft market

  • Bajaj Finance AUM +24%, PAT +27.6%; lending diversification strong

  • Emerging businesses on breakeven path (Direct Q4 FY27, Health Q4 FY28)

  • Life insurance profit in line with guidance

The first three hold solidly. Bajaj Life's operational turnaround is unambiguous: VNB expansion, margin accretion, and cost discipline (Bajaj Life 2.0) are all executing. General Insurance's strategy of tactical motor slowdown (growth ~10% vs. industry ~12%) and disciplined underwriting is defensible in a soft market; the 103.9% COR is industry-leading. Finance and Housing show classic Bajaj strength: diversified AUM (retail, SME, gold loans, commercial vehicles), resilient credit quality (GNPA 0.96%, NNPA 0.39%), and sustainable growth. Emerging businesses are tracking to breakeven, though timelines have slipped vs. the original 1–2 year guidance (Finserv Direct Q4 FY27 is on track, but Health now Q4 FY28 is extended). The outlier: Life profit, which fell 70% despite VNB surging 87%—a valuation and non-recurring items story, not an underwriting one.

What changed on this call

Three substantive shifts from prior quarters: (1) Life Insurance turnaround now confirmed. The VNB and margin expansion targets are being met, validating the Bajaj Life 2.0 restructuring and new partnership model (20+ new group partnerships in 15 months, reducing concentration from 50% to a diversified base). (2) Emerging business timelines extended but on track. Finserv Direct is approaching Q4 FY27 breakeven (originally guided 1–2 years; broadly tracking) with trail revenue growing (₹15 Cr this quarter, growing QoQ) reducing linearity pressure. Health now targets Q4 FY28 breakeven (1-year extension vs original 1–2 year guidance) with planned capex through Q3/Q4; Markets remains loss-making but the model is operationalizing. Capex of ₹200–300 Cr over the next 6 quarters is required to sustain these paths. (3) Ind AS transition clarity (April 2027). Insurance subsidiaries will move to fair-value accounting, shifting acquisition cost amortization and long-term liability discounting; management sees potential arbitrage on onerous contracts and liability release, adding near-term volatility but longer-term transparency.

Bull-bear ledger

  • Bajaj Finance is a compounding machine (AUM +24%, PAT +27.6%, NPA improving)

  • Life Insurance turnaround is real and sustainable (VNB +87%, NBM +480 bps, cost discipline working)

  • General Insurance best-in-class underwriting discipline (COR 103.9% vs ~120% industry)

  • Emerging businesses on breakeven paths but still burning ₹200–300 Cr capex / 6 qtrs

  • Reported PAT growth lags revenue due to capital gains collapse and soft insurance market

  • Motor segment deliberately slowed; near-term premium growth capped in a soft market

  • Insurance pricing cycle remains soft; recovery dependent on catastrophes or industry rationalization

  • Persistency dips in Life segments; near-term VNB growth may moderate from 87% base

Risks, ranked by impact on a holder

What should concern an investor, in order

Soft insurance pricing cycle persists

High

Industry COR at 120%+; Bajaj at 103.9% shows skill but near-term margins are capped. If catastrophes don't force hardening, cycle could remain soft for years. Motor loss ratios elevated; Bajaj is disciplined but growth will remain muted.

Earnings quality / capital gains volatility

High

Life PAT fell 70% and GI profit fell 27% despite operational strength; both driven by capital gains collapse. Ind AS transition (April 2027) will smooth this, but until then reported earnings will remain choppy and confuse valuation signals.

Emerging businesses consume capital without clear profitability

Medium

Finserv Direct, Health, Markets, and new ALT/Reinsurance ventures still loss-making. Capex ₹200–300 Cr over next 6 quarters required. Health breakeven timeline slipped from 1–2 years to Q4 FY28. If timelines slip further, credibility on emerging ROI erodes.

Supreme Court motor third-party ruling tail risk

Medium

Homemakers immaterial in Bajaj portfolio (per management), but if ruling is applied broadly, reserves could face charge/release swing. GIC filed review petition; uncertainty persists until resolved.

Persistency dips in Life segments

Medium

VNB growth at 87% is exceptional but faces headwinds from lower persistency in certain product segments. If dips accelerate, VNB growth moderation from this base is inevitable.

How the market is positioned

The stock rallied 3.3% on day 1 post-result (delivery 45%), a modest affirmation but not a rave. However, at ₹2,105 (as of 4 Aug 2026), Bajaj Finserv is now 4.1% below its all-time high and trading at overbought technicals (RSI 82.9), suggesting the move has run ahead of fundamental enthusiasm. The stock is up 31.8% from its 52-week low but volume is increasing, indicating momentum trading rather than accumulation. On ownership, institutional sentiment is mixed: FII holdings fell 82 basis points QoQ to 7.24% (selling into strength), while DII added 102 basis points to 11.76% (domestic support). Promoter holdings remain stable at 58.71%, a slight trim. The price action and flows together suggest the market liked the result and Life turnaround narrative, but is cautious on valuation at current levels—a classic 'sell the rally' setup if emerging business timelines slip or insurance pricing remains soft.

What to watch next

Three concrete catalysts that reset the debate
  • 1 · Finserv Direct Q4 FY27 breakeven milestone (imminent)

    The biggest emerging business is on the cusp of cash-flow breakeven. Once that's achieved, investor focus shifts to path to profitability and ROIC contribution. Trail revenue (₹15 Cr this quarter, growing QoQ) will accelerate the timeline.

  • 2 · Insurance pricing cycle hardening signal

    If major catastrophes occur or industry players announce discipline-driven slowdowns, pricing could recover within 12–18 months. That's the biggest upside catalyst for GI and Life margins. Watch industry commentary on motor and crop loss ratios.

  • 3 · Ind AS transition impact (effective April 2027)

    The shift to fair-value accounting and acquisition cost amortization will reshape insurance earnings. Management signals potential arbitrage on onerous contracts and long-term liability discounting. Near-term volatility, but longer-term clarity on earnings quality.

The number to track

Don't look at reported PAT. Track Bajaj Finance PAT growth and Bajaj Life VNB growth. If Finance PAT continues to grow mid-to-high 20s and Life VNB sustains 50%+ (even if 87% moderates as it should on a higher base), the turnaround is real and deserves re-rating. If either falters, it's a red flag that operational excellence is slipping beneath macro noise.

Bajaj Finserv is a Hold. The operational story—especially Life Insurance's turnaround and Finance's diversified growth—is genuine and well-executed. But reported earnings are noisy, emerging businesses are still loss-making, and the insurance market macro is working against near-term margins. The company is disciplined, the management is credible, and the dividend is safe. For existing holders, the fundamentals justify staying put. For new buyers, wait for (a) Finserv Direct profitability confirmation, (b) a clearer sign of insurance pricing recovery, or (c) a 10–12% pullback from here—which would offer a better entry and de-risk the overbought technicals.

Informational and educational content only. Not investment advice.